InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Licitra Karen A, Director. Officer active across 2 companies, notably SI-BONE, Inc.. Aggregated, 7 reports have been logged. History available since 25 June 2021. The latest transaction was disclosed on 17 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
20,541 shares0Common StockSEC:0001140361-24-033628:0
17,041 shares0Common StockSEC:0001140361-23-035719:0
7,060 shares0Common StockSEC:0001567619-22-014361:0
5,738 shares0Common StockSEC:0001567619-21-013921
5,738 shares0Common StockSEC:0001567619-21-013921:0
10,297 shares@ US$4.3250.0% of flowCommon StockSEC:0001562180-21-004531
10,297 shares@ US$4.320.0059% mcap50.0% of flowCommon StockSEC:0001562180-21-004531:0
7 of 7 declarations
About Licitra Karen A
Karen A. Licitra is a Board Member at SI-BONE, Inc. and Angiodynamics Inc. She plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. Licitra is valued for her expertise in the healthcare sector.
